Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 43.00 | |
25 mg | In stock | $ 66.00 | |
50 mg | In stock | $ 85.00 | |
100 mg | In stock | $ 142.00 | |
200 mg | In stock | $ 183.00 | |
500 mg | In stock | $ 297.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997. |
Synonyms | AA 2414, ABT-001 |
Molecular Weight | 354.44 |
Formula | C22H26O4 |
CAS No. | 112665-43-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200.3 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Seratrodast 112665-43-7 DNA Damage/DNA Repair GPCR/G Protein Immunology/Inflammation Metabolism Neuroscience Prostaglandin Receptor COX PPAR Inhibitor inhibit AA 2414 ABT001 ABT-001 ABT 001 AA-2414 AA2414 inhibitor